H1B Salary Data

Home › Employers › Adventist Health Delano

Adventist Health Delano: H-1B salaries and sponsorship

Adventist Health Delano filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $114,712.

Applications (LCAs)4
Certified3
Employer addressDelano, CA
H-1B dependent employerNo
Median offered salary$114,712
Middle half of salaries$96,366–$146,026
10th–90th percentile$85,359–$164,815

Does Adventist Health Delano sponsor H-1B visas?

Adventist Health Delano filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on May 9, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Clinical Laboratory Scientist2$114,712
Registered Dietitian1$78,021
Pharmacist1$177,341

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$78,021
FY20243$146,026

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Clinical Laboratory Scientist$114,712
Level I
Delano, CAMay 9, 2024Jun 14, 2024Certified
Clinical Laboratory Scientist$114,712
Level II
Delano, CAMay 9, 2024Jun 14, 2024Withdrawn
Pharmacist$177,341
Level IV
Delano, CAFeb 5, 2024Feb 19, 2024Certified
Registered Dietitian$78,021
Level II
Delano, CAJan 4, 2023Mar 14, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).